U.S. Clinical Laboratory Testing Sector Revenue to Jump to $63.8 Billion by 2016
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 06/21/12 -- TriMarkPublications.com cites in its newly published " Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report that U.S. sector revenue will jump to $63.8 billion by 2016. For more information, visit: .
can be categorized into two main modalities: clinical testing and anatomical pathology testing. Principal tests undertaken include complete blood counts, prothrombin and coagulation testing, thyroid stimulating hormone (TSH), lipid panels, blood gases and electrolytes, cardiac markers, infectious diseases, whole-blood glucose, drugs of abuse testing (DAT), urinalysis, coagulation and cardiac monitoring. In the U.S., approximately 85% of clinical diagnostic testing is currently conducted in hospital-based and commercial laboratories.
The " Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report covers:
Medicare Clinical Lab Services Spending Trends
Hospital-based Clinical Laboratories
Commercial
Physician Office Laboratories (POLs)
Workplace Drugs-of-Abuse Testing
Clinical Toxicology
Vitamin D Testing
Diabetes (Glucose) Testing
Molecular Diagnostic Testing
Cardiac Markers
Blood Bank Screening
Genetic Testing
Point of Care Testing
Anatomic Pathology
Immunodiagnostics
Opiate Testing
The " Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies" report examines companies manufacturing equipment and supplies in the world. Companies covered include: ACM Medical, Alere, American Esoteric (Sonic), American Pathology, AmeriPath (Quest), ARUP, Athena, Aurora, Bio-Reference, BioTech MedLab, Caris, CBLPath, Centrex Clinical, Clarient, Clinical Reference, Clongen, CompuNet Clinical, EndoChoice Pathways, Enzo Biochem, Esoterix (LabCorp), Exagen, Geneva, Genomic Health, Genzyme, IBT, Integrated Regional (IRL), LabCorp, MEDTOX Scientific, Meriter Health Services, Mid America Clinical (MACL), Monogram, Myriad, National Jewish Medical and Research Center, Parkway, Pathology, Predictive, Psychemedics, Quest, RDL Reference, Satellite Services, Signal, Solstas, Sonic and Spectra.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 21.06.2012 - 11:45 Uhr
Sprache: Deutsch
News-ID 1126717
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"U.S. Clinical Laboratory Testing Sector Revenue to Jump to $63.8 Billion by 2016
"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
